Tarlatamab
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
Tarlatamab
Sep 17, 2024, 10:23 |
Insight
Sumanta K. Pal: Misha Beltran highlighting role of DLL3 in neuroendocrine prostate cancer
Sumanta K. Pal shared on X: "Crystal clear talk from Misha Beltran highlighting role of…
Sep 15, 2024, 01:34 |
Insight
Some perspective on TRUST-II with talectrectinib
IASLC shared on X: “ In this episode, Narjust Florez and Stephen V Liu, recap…
Sep 10, 2024, 16:09 |
Societies
Highlights from WCLC24 by Stephen V Liu Part 2
The WCLC24 is taking place at the San Diego Convention Center from September 7 to…
Sep 10, 2024, 16:04 |
Societies
Insights from WCLC24 by Sarah Waliany
The WCLC24 is taking place at the San Diego Convention Center from September 7 to…
Sep 4, 2024, 06:47 |
Insight
Jarushka Naidoo: Intracranial activity of Tarlatamab in 2L SCLC in Ph I DeLLphi-300 Trial
Jarushka Naidoo shared on X: "Intracranial activity of Tarlatamab in 2L SCLC in Ph I…
Jul 11, 2024, 13:02 |
Blog
Eric Singhi: Clinical updates for patients with small cell lung cancer
Eric Singhi shared a post by Oncology Brothers on X, adding: "Always a great time…
Jul 6, 2024, 13:16 |
Blog
Wafik El-Deiry about DAVA Oncology 3rd Global Thoracic Malignancies Summit
Wafik El-Deiry shared posts on LinkedIn and X: . "Grateful for opportunity to speak about…
Jun 8, 2024, 11:29 |
Insight
Key Insights You Don't Want to Miss - The Babak Lab
The Babak Lab shared on LinkedIn: "Weekly Digest: Key Insights You Don't Want to Miss!…
Jun 2, 2024, 13:01 |
Blog
Moffitt Cancer Center is the first healthcare provider in the US to commercially administer a newly-approved therapy for Small Cell Lung Cancer
Moffitt Cancer Center shared on their X/Twitter: ''Moffitt is the first healthcare provider in the…
May 31, 2024, 07:45 |
Insight
Aakash Desai: ASCO24 set to showcase some SCLC research, hopefully pushing boundaries in this field
Aakash Desai, Assistant Professor at O’Neal Comprehensive Cancer Center at UAB, shared on LinkedIn: “T-2 ASCO24…
May 19, 2024, 10:55 |
Insight
Dhruba Deb: The 8 SCLC projects Lung Cancer Research Foundation recently funded
Dhruba Deb, Senior Director of Research and Administration at Lung Cancer Research Foundation, shared on…
May 18, 2024, 02:46 |
Drugs
Vivek Subbiah: US FDA granted accelerated approval to tarlatamab-dlle
Vivek Subbiah shared on X: "New FDA Approval. Today the US FDA granted accelerated approval…
May 15, 2024, 09:38 |
Blog
Tanja Obradovic: Important PDUFA on June 12th is coming up
Tanja Obradovic shared a post on LinkedIn: "Important PDUFA on June 12th is coming up that…
Dec 26, 2023, 13:35 |
Insight
Erman Akkus: SUMMARIES OF 5 TOP-READ ARTICLES OF Journal of Clinical Oncology and JCO Precision Oncology in 2023!
Erman Akkus, Medical Oncology Fellow at Ankara University, shared on X/Twitter: "SUMMARIES OF 5 TOP-READ…
All:
14
Posts:
1 - 100
Making Personal Experience a Political Priority: Insights from EU Commissioner Stella Kyriakides
Zolbetuximab is now approved by the US FDA
Highlights from NFCR’s GSAC24
SIOP Honoured Hansjörg Riehm with the 2024 Lifetime Achievement Award
Margaret Foti has received the 2024 Beacon Award for Women Leaders in Oncology
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube